THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: REAL WORLD EXPERIENCE

被引：0
|
作者：
Shalabi, Ahmed [1 ]
Banerjee, Rwiti [1 ]
Padley, Jessica [1 ]
Appleby, Richard [1 ]
Johnston, Emma [1 ]
机构：
[1] Chelsea & Westminster Univ Hosp NHS Fdn Trust, West Middlesex Univ Hosp, London, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.224
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P149
引用
收藏
页码：A120 / A120
页数：1
相关论文
共 50 条
  • [31] Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
    Alsoud, Dahham
    Vermeire, Severine
    Verstockt, Bram
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 17 - 30
  • [32] The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience
    Mitchell, Robert A.
    Shuster, Constantin
    Shahidi, Neal
    Galorport, Cherry
    DeMarco, Mari L.
    Rosenfeld, Gregory
    Enns, Robert A.
    Bressler, Brian
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2016
  • [33] Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort
    Azzam, Nahla
    Aljebreen, Abdulrahman
    Alharbi, Othman
    Charabaty, Aline
    Alanazi, Mohammed
    Alkuwaykibi, Nashmi
    Alfaraidi, Jowaher
    Bashamil, Ahmad
    Almansour, Tarik
    Almadi, Majid
    [J]. ARAB JOURNAL OF GASTROENTEROLOGY, 2021, 22 (01) : 66 - 72
  • [34] Therapeutic drug monitoring in inflammatory bowel disease
    Kopylov, Uri
    Ben-Horin, Shomron
    Seidman, Ernest
    [J]. ANNALS OF GASTROENTEROLOGY, 2014, 27 (04): : 304 - 312
  • [35] Therapeutic drug monitoring in inflammatory bowel disease
    Jossen, Jacqueline
    Dubinsky, Marla
    [J]. CURRENT OPINION IN PEDIATRICS, 2016, 28 (05) : 620 - 625
  • [36] Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
    Wiken, Thea H.
    Hoivik, Marte L.
    Buer, Lydia
    Warren, David J.
    Bolstad, Nils
    Moum, Bjorn A.
    Anisdahl, Karoline
    Smastuen, Milada C.
    Medhus, Asle W.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, : 863 - 873
  • [37] Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
    Sider, S.
    Cococcioni, L.
    ElZein, A.
    Chadokufa, S.
    Buckingham, R.
    Shah, N.
    Ocholi, A.
    Borrelli, O.
    Kiparissi, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S566 - S566
  • [38] Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience
    Kopylov, Uri
    Avni-Biron, Irit
    Ron, Yulia
    Koslowsky, Benjamin
    Waterman, Matti
    Daher, Saleh
    Ungar, Bella
    Schwartz, Doron
    Zittan, Eran
    Openhaim, Michal
    Yanai, Henit
    Maharshak, Nitsan
    Shitrit, Ariella Bar Gil
    Naftali, Timna
    Eliakim, Rami
    Chowers, Yehuda
    Ben-Horin, Shomron
    Dotan, Iris
    [J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 (01) : 68 - 74
  • [39] IMPACT OF THERAPEUTIC DRUG MONITORING ON OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hussenbux, Arif
    Chopra, Tanya
    Stearns, Rebecca
    Ravindran, Rahul
    Patodi, Nishant
    De Silva, Aminda
    [J]. GUT, 2021, 70 : A100 - A100
  • [40] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    [J]. GASTROENTEROLOGY, 2018, 154 (01) : S105 - S106
12345